上海优宁维生物科技股份有限公司代理商

19

手机商铺

qrcode
商家活跃:
产品热度:
  • NaN
  • 0
  • 0
  • 2
  • 2
代理商

上海优宁维生物科技股份有限公司

入驻年限:19

  • 联系人:

    上海总部

  • 所在地区:

    上海 浦东新区

  • 业务范围:

    试剂

  • 经营模式:

    代理商

在线沟通

公司新闻/正文

BioXcell特色产品推荐之:InVivoMAb anti-mouse PD-L1 (B7-H1)

568 人阅读发布时间:2023-01-17 16:35

一 产品介绍
PD-L1 是一种 40 kDa I 型跨膜蛋白,属于 Ig 超家族的 B7 家族。PD-L1 在 T 淋巴细胞、B 淋巴细胞、NK 细胞、树突状细胞以及 IFNγ 刺激的单核细胞、上皮细胞和内皮细胞上表达。PD-L1 与其受体 PD-1 结合,PD-1 存在于 CD4 和 CD8 胸腺细胞以及活化的 T 和 B 淋巴细胞和骨髓细胞上。PD-L1 与 PD-1 的结合导致 TCR 介导的 T 细胞增殖和细胞因子产生的抑制。PD-L1被认为在肿瘤免疫逃避中发挥重要作用。诱导的 PD-L1 表达在许多肿瘤中很常见,并导致肿瘤细胞对 CD8 T 细胞介导的裂解的抵抗力增加。在黑色素瘤小鼠模型中,通过使用阻断 PD-L1 和 PD-1 之间相互作用的抗体进行治疗,可以暂时抑制肿瘤生长。10F.9G2 抗体已显示可阻断 PD-L1 和 PD-1 之间以及 PD-L1 和 B7-1 (CD80) 之间的相互作用。

 新闻图片1
二 产品详情

产品详情
产品编号 BE0101
同型对照 大鼠 IgG2b,κ
推荐的同种型对照 InVivo MAb rat IgG2b 同种型对照
推荐的稀释缓冲液 InVivo Pure pH 6.5 稀释缓冲液
免疫原 Mouse CD274
产品应用 体内PD-L1 阻断、免疫荧光 免疫、组织化学(冷冻)、流式细胞术
  Western blot
产品组分 PBS,pH 6.5不含稳定剂或防腐剂
内毒素 <2EU/mg (<0.002EU/μg)通过 LAL试验测定
纯度 >95%由 SDS-PAGE 确定
无菌性 0.2 μM 过滤
生产 在无动物设施中从组织培养上清液中纯化
纯化 Protein G
RRID AB_10949073
分子量 150 kDa
贮存 抗体溶液应在 4°C 下以原液浓度储存


 三 已发表文献

用途 已发表文献
in vivo PD-L1 blockade Grasselly, C., et al. (2018). "The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent" Front Immunol 9: 2100
in vivo PD-L1 blockade Stathopoulou, C., et al. (2018). "PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells" Immunity 49(2): 247-263 e247
in vivo PD-L1 blockade Aloulou, M., et al. (2016). "Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells" Nat Commun 7: 10579
in vivo PD-L1 blockade Ngiow, S. F., et al. (2015). "A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1" Cancer Res 75(18): 3800-3811
in vivo PD-L1 blockade Jaworska, K., et al. (2015). "Both PD-1 ligands protect the kidney from ischemia reperfusion injury" J Immunol 194(1): 325-333
in vivo PD-L1 blockade Kim, J., et al. (2015). "Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help" Nat Commun 6: 7994
in vivo PD-L1 blockade Zander, R. A., et al. (2015). "PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity" Cell Host Microbe 17(5): 628-641
in vivo PD-L1 blockade Tkachev, V., et al. (2015). "Programmed death-1 controls T cell survival by regulating oxidative metabolism" J Immunol 194(12): 5789-5800
in vivo PD-L1 blockade Twyman-Saint Victor, C., et al. (2015). "Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer" Nature 520(7547): 373-377
in vivo PD-L1 blockade Rutigliano, J. A., et al. (2014). "Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells" J Virol 88(3): 1636-1651
in vivo PD-L1 blockade Yang, X., et al. (2014). "Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses" Cancer Cell 25(1): 37-48.
in vivo PD-L1 blockade Dolina, J. S., et al. (2014). "Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice" Hepatology 59(4): 1351-1365
in vivo PD-L1 blockade Deng, L., et al. (2014). "Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice" J Clin Invest 124(2): 687-695
in vivo PD-L1 blockade Dietze, K. K., et al. (2013). "Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads" PLoS Pathog 9(12): e1003798
in vivo PD-L1 blockade Willimsky, G., et al. (2013). "Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance" J Clin Invest 123(3): 1032-1043
in vivo PD-L1 blockade Hafalla, J. C., et al. (2012). "The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology" PLoS Pathog 8(2): e1002504.
in vivo PD-L1 blockade Zhang, L., et al. (2009). "PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model" Blood 114(8): 1545-1552.


详情请咨询 BioXcell 中国授权代理-优宁维生物

上海优宁维生物科技股份有限公司

试剂 | 耗材 | 仪器 | 软件 | 定制 | 实验服务 | 供应链

免费热线:4008-168-068

咨询邮箱:info@univ-bio.com

订购商城:www.univ-bio.com

微信公众平台:优宁维抗体专家,欢迎关注!

小优博士(小程序):5大课堂, 让你的科研不再难!


上一篇

免疫共沉淀实验·基础篇

下一篇

BioXcell特色抗体之:neutralizing and detecting cytokines and their receptors

更多资讯

我的询价